^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

hydroxychloroquine

Company:
Generic mfg.
Drug class:
Immunomodulator, PLA2 inhibitor
Related drugs:
15h
Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis (clinicaltrials.gov)
P3, N=210, Recruiting, National Taiwan University Hospital
New P3 trial
|
hydroxychloroquine
2d
Nrf2 modulates macrophage foam cells senescence and autophagy activation. (PubMed, Toxicol Mech Methods)
Furthermore, inhibiting the late stage of autophagy with hydroxychloroquine (HCQ) decreased cell viability, while early-stage autophagy inhibition using 3-Methyladenine (3-MA) had no significant effect. These results highlight the critical role of Nrf2 in controlling foam cell development, senescence, and autophagic processes, giving valuable insights into potential therapeutic targets for atherosclerosis.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • MMP9 (Matrix metallopeptidase 9)
|
hydroxychloroquine
8d
Repurposing Antimalarials for Oral Cancer: Selective Efficacy of Hydroxychloroquine on Gingival Squamous Cell Carcinoma. (PubMed, Int J Mol Sci)
Chloroquine (CQ) and hydroxychloroquine (HCQ) have shown potential owing to their roles in autophagy modulation and immune regulation. Gene expression profiling and flow-cytometry analyses revealed cell-type-specific differences in apoptosis, mitochondrial potential, and DNA damage, suggesting HCQ's selective anti-tumor potential in gingival carcinoma. These findings highlight HCQ as a repurposed adjuvant therapy that modulates autophagy and apoptosis to enhance chemosensitivity in oral cancer.
Journal
|
CA9 (Carbonic anhydrase 9) • TFEB (Transcription Factor EB 2)
|
hydroxychloroquine
9d
Case Report: Possible association between dermatomyositis and Trastuzumab Deruxtecan therapy of triple-negative breast cancer patient. (PubMed, Front Immunol)
The condition remained poorly controlled despite administration of Prednisone combined with Hydroxychloroquine, and showed no significant improvement after adding methotrexate. reported here findings suggest that T-DXd may trigger multi-system involvement through immune-mediated mechanisms, resulting in drug-induced dermatomyositis and interstitial pneumonia. Our findings highlight the need for heightened vigilance regarding such immune-related adverse events during T-DXd therapy, where early recognition and intervention are critically important to avoid irreversible and possibly fatal complications.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • TGFB1 (Transforming Growth Factor Beta 1)
|
HER-2 expression
|
Enhertu (fam-trastuzumab deruxtecan-nxki) • methotrexate • prednisone • hydroxychloroquine
16d
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi (clinicaltrials.gov)
P4, N=1000, Active, not recruiting, Liverpool School of Tropical Medicine | Recruiting --> Active, not recruiting
Enrollment closed
|
hydroxychloroquine
18d
Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study. (clinicaltrials.gov)
P4, N=50, Not yet recruiting, Radboud University Medical Center
New P4 trial
|
hydroxychloroquine
1m
Proteins linked to type II interferon response in Sjögren's disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy. (PubMed, Front Immunol)
These data support a significant role for a type II IFN-associated immune response in SjD pathogenesis, which is targeted by LEF/HCQ. Proteins associated with type II IFN-driven immune responses hold potential to monitor disease activity and predict treatment response.
Clinical • Journal • IO biomarker
|
IFNG (Interferon, gamma) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CD70 (CD70 Molecule) • CXCL11 (C-X-C Motif Chemokine Ligand 11)
|
hydroxychloroquine • leflunomide
1m
Impact of trehalose and hydroxychloroquine on the function of BRAF (V600E)-siRNA in the A375 melanoma cells. (PubMed, Iran J Basic Med Sci)
TRE, either alone or combined with siRNA, showed limited efficacy and may counteract the apoptotic benefits of HCQ. Conversely, HCQ, whether used alone or in combination with siRNA, enhanced apoptosis, suggesting promise as a potential treatment for melanoma.
Journal
|
BRAF (B-raf proto-oncogene) • RAF1 (Raf-1 Proto-Oncogene Serine/Threonine Kinase) • CASP3 (Caspase 3) • PIK3R3 (Phosphoinositide-3-Kinase Regulatory Subunit 3)
|
BRAF V600E • BRAF V600
|
hydroxychloroquine
1m
Retinoic Acid plus Hydroxychloroquine Sulfate and Methylprednisolone in Patients with Erosive Oral Lichen Planus: A Randomized and Controlled Clinical Trial (ChiCTR2500108290)
P4, N=146, Not yet recruiting, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Shanghai Ninth People's Hospital, Shanghai JiaoTong University
New P4 trial
|
hydroxychloroquine
1m
Trial completion • Trial completion date
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • gemcitabine • albumin-bound paclitaxel • hydroxychloroquine • NG-350A
1m
Mutant and Wild-type RAS Crosstalk and Stoichiometric Deficiencies are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma. (PubMed, Cancer Res)
To substantiate the preclinical findings, the utility of MEKi in combination with the autophagy inhibitor hydroxychloroquine was analyzed in patients with KRASG12R mutated metastatic PDAC...Three patients had impressive disease control: two had stable disease of 11 and 22.7 months, and one achieved a partial response with an 83% decrease in tumor size that lasted for 8.9 months. Overall, this work highlights how systems-based approaches in precision medicine can uncover mechanistic insights to guide the identification of PDAC patients most likely to benefit from tailored therapeutic strategies.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • NRAS (Neuroblastoma RAS viral oncogene homolog) • HRAS (Harvey rat sarcoma viral oncogene homolog) • NF1 (Neurofibromin 1) • RAS (Rat Sarcoma Virus)
|
KRAS mutation • KRAS G12D • KRAS G12R • RAS wild-type • KRAS G12 • NRAS wild-type • NRAS G12
|
hydroxychloroquine
2ms
Amyopathic Dermatomyositis Presenting With Oral Mucocutaneous Lesion and No Muscle Involvement in an Elderly Woman: A Mimicry of Fungal Infection and Eczema. (PubMed, Cureus)
Systemic corticosteroids and hydroxychloroquine were initiated, followed by mycophenolate mofetil, with limited response. This case illustrates the atypical presentation of ADM and the challenges in establishing an early diagnosis when muscle involvement is absent. It highlights IVIG as an effective option for treatment-resistant disease and underscores the importance of maintaining a high index of suspicion, pursuing thorough diagnostic evaluation, and ensuring long-term monitoring for interstitial lung disease and malignancy, even in patients who present with isolated cutaneous findings.
Journal
|
IFIH1 (Interferon Induced With Helicase C Domain 1)
|
hydroxychloroquine